CD19-CAR immunotherapy

· University College London

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-CAR immunotherapy, covering 2018-05-17 to 2018-05-17. Get the full timeline:

Most recent: Clinical Trial Update: CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]